In this issue of THE JOURNAL, Albert and colleagues1
present the main results of the Pravastatin Inflammation/CRP Evaluation (PRINCE)
study, a randomized clinical trial and prospective cohort study evaluating
the effects of pravastatin on levels of high sensitivity C-reactive protein
(CRP). The investigators randomly assigned men and women with elevated low-density
lipoprotein cholesterol (LDL-C) levels and no apparent coronary disease to
receive placebo or pravastatin to assess the change in CRP levels at 24 weeks
independently of the change in lipids. An additional cohort of patients with
established coronary disease received open label pravastatin to determine
the effect on CRP among these patients as well.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 5
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.